DOI:
10.1055/s-00000002
Aktuelle Dermatologie
LinksClose Window
References
Topalian SL BS, Hollebecque A, Awada A. et al.
Non-comparative, Open-label, Multiple Cohort, Phase 1/2 Study to Evaluate Nivolumab in Patients With Virus-associated Tumors (CheckMate 358): Efficacy and Safety in Merkel Cell Carcinoma.
Cancer Res 2017;
DOI: 10.1158/1538-7445.AM2017-CT074. [Abstract CT074]
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.